These results imply that PHB2 plays an oncogenic or growth-promoting role in HCC, reflecting the cell-based findings that overexpression of PHB2 enhanced cell proliferation, migration, and resistance to anticancer drugs (Fig. S11), and overexpression of GALNT14 increased the levels of PHB2 (Fig. 5A). Here, PHB2 is linked to hepatocellular carcinoma.